Woods Christopher W, Cheng Allen C, Fowler Vance G, Moorefield Mary, Frederick Joyce, Sakoulas George, Meka Venkata G, Tenover Fred C, Zwadyk Peter, Wilson Kenneth H
Clinical Microbiology, Durham Veterans Administration Medical Center, Durham, NC 27705, USA.
Clin Infect Dis. 2004 Apr 15;38(8):1188-91. doi: 10.1086/383027. Epub 2004 Apr 5.
Clinical management of infective endocarditis (IE) is expected to become more difficult with the emergence of Staphylococcus aureus with reduced susceptibility to vancomycin (SARV) in the United States and worldwide. We report the strain characterization and treatment of a patient with SARV IE.
在美国和全球范围内,随着对万古霉素敏感性降低的金黄色葡萄球菌(SARV)的出现,感染性心内膜炎(IE)的临床管理预计将变得更加困难。我们报告了一名患有SARV IE患者的菌株特征及治疗情况。